Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer
Conditions
Pancreatic Cancer
Conditions: official terms
Pancreatic Neoplasms
Conditions: Keywords
Proton radiation, Chemotherapy, Pancreatic cancer, Postoperative
Study Type
Interventional
Study Phase
Phase 2
Study Design
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Intervention
Name: Proton radiation Type: Radiation
Name: Gemcitabine Type: Drug
Overall Status
Recruiting
Summary
The purpose of this study is to find out what effects, good and/or bad, proton radiation combined with chemotherapy has on resected pancreatic cancer.
Detailed Description
Proton radiation with concomitant chemotherapy
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- Histologic proof of primary head of pancreas invasive adenocarcinoma managed with a potentially curative resection

- Post resection CA19-9 tumor marker baseline

Exclusion Criteria:

- Previous history of invasive malignancy (except non-melanoma skin cancer and low to intermediate risk prostate cancer) unless the patient has been disease free for at least 5 years prior to study consent
Location
University of Florida Proton Therapy Institute
Jacksonville, Florida, United States
Status: Recruiting
Contact: Intake Coordinator - 904-686-6009
Start Date
October 2011
Completion Date
February 2024
Sponsors
University of Florida
Source
University of Florida
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page